SERMs

Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals